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Plantextracts arethemostattractive sourcesofnewerdrugs andhavebeen showntoproduce promisingresultsforthetreatment of
gastric ulcers. Karanjin, a furano-ﬂavonoidhas been evaluated for anti-ulcerogenic property by employing adult male albino rats.
Karanjin (>95% pure) was administered to these rats in two diﬀerent concentrations, that is, 10 and 20 mg kg−1 b.w. Ulcers were
induced in the experimental animals by swim and ethanol stress. Serum, stomach and liver-tissue homogenates were assessed for
biochemical parameters. Karanjin inhibited 50 and 74% of ulcers induced by swim stress at 10 and 20 mg kg−1 b.w., respectively.
Gastricmucinwasprotected upto85% incaseofswimstress,whereas only47% mucinrecovery wasseeninethanolstress induced
ulcers. H+,K +-ATPase activity, which was increased 2-fold in ulcer conditions, was normalized by Karanjin in both swim/ethanol
stress-induced ulcer models. Karanjin could inhibit oxidative stress as evidenced by the normalization of lipid peroxidation and
antioxidant enzyme (i.e., catalase, peroxidase and superoxide dismutase) levels. Karanjin at concentrations of 20mgkg−1 b.w.,
when administered orally for 14 days, did not indicate any lethal eﬀects. There were no signiﬁcant diﬀerences in total protein,
serum glutamate pyruvate transaminase, serum glutamate oxaloacetate transaminase and alkaline phosphatase between normal
and Karanjin-treated rats indicating no adverse eﬀect on major organs. During treatment schedule, animals remained as healthy
as control animals with normalfood and water intake and body weight gain.
1.Introduction
Gastric hyperacidity and gastroduodenal ulcer are common
global problems and are caused by a lack of equilibrium
between the gastric aggressive and the mucosal defensive
factors [1]. The etiology of gastroduodenal ulcers is inﬂu-
enced by various aggressive and defensive factors such as
acid–pepsin secretion, parietal cell activation, reduction in
mucous secretion, mucosal blood ﬂow, cellular regeneration
process and endogenous protective agents (prostaglandin
and epidermal growth factors) [2]. Other factors that con-
tribute to ulcers include improper dietary habits, excessive
ingestion of non-steroidal anti-inﬂammatory agents, stress
and infection by Helicobacter pylori [3].
Several pharmaceutical products have been employed
consistently for the treatment of gastric ulcers aiming to
reduce mortality and morbidity rates. However, adverse
eﬀects and limitations posed by them on the use of these
drugs against only a set of population warranted alternative
therapies. Despite the progress in ulcer therapy from vago-
tomy to anti-cholinergic drugs, histamine H2 antagonists,
antacids, proton-pump inhibitors, and so forth, [4] in recent
years growing interest has been toward the utilization of
natural products, especially those derived from plant foods
[5]and plant parts [6, 7], which are often designated as com-
plementary and alternative medicines (CAMs), particularly
as nutraceutical [8] and herbal medicines [9], respectively.
Recent studies on complementary and alternative
medicines (CAMs) in fact suggested that CAMs play a
challengingroleininhibitingseveralstepsofvariousdiseases,
including chronic diseases such as ulcers, cancers, diabetes,
inﬂammation, and so forth, similar to those of allopathic2 Evidence-Based Complementary and Alternative Medicine
medicines [10, 11], but with no or insigniﬁcant side eﬀects
[12]. The National Centre for Complementary and Alterna-
tive Medicine and the National Centre for Health Statistics,
USA, indeed declared that ∼38% of Americans use CAMs
[13] and this is evidenced by signiﬁcant increase of demand
in the world market for alternative drugs from plants—
phytomedicines [14].
We have previously reported the gastroprotective prop-
erties from extracts of medicinal plants [15, 16] and natural
bioactive compounds isolated from microalgae [17]. In the
current study, we explored the anti-ulcerative property of
Karanjin, a furano-ﬂavonoid isolated from karanja seeds.
The study has been undertaken in the light of the previous
observations [18], which have reported an anti-ulcer prop-
erty in crude extracts of karanja, which potentially contain
karanjin.
Pongamia pinnata (L.) Pierre (Leguminosae, Papil-
ionaceae; synonym Pongamia glabra Vent.), is popularly
knownas“Karanj”or“Karanja” inHindi[19].Itisoneofthe
widely grown forest trees. The seed contains 33–36% oil, 20–
28% protein and is characterized by the presence of minor
constituents such as ﬂavonoids. The seed oil is known as
karanja oil and is recognized for medicinal properties [20].
Flavonoids, which occur naturally in plant foods, have been
associated with reduced risk factor of cardiovascular diseases
and are reported to possess antioxidant activity and anti-
ulcerogenic and analgesic eﬀects.
In the current study, we investigated the anti-ulcerative
property of karanjin, isolated from karanja seeds. Proof of
this bioactivity would envisage the dual activity of exploring
karanjin isolation for medicinal purposes in addition to
the extraction of karanja oil, currently being used for
leathersoftening and in ayurvedicpreparations because ofits
pharmacological values. This article highlights the anti-ulcer
potential of karanjin in both in vitro and in vivo models.
2.Methods
2.1. Chemicals. All the chemicals used were of high-
performance liquid chromatography (HPLC) grade or ana-
lytical grade (E. Merck). Standard chemicals used were
obtained from Sigma chemicals Co., USA.
2.2. Plant. Mature karanja seeds were procured from M/s
Suresh Forestry Network, Chickballapur, Karnataka, India.
2.2.1.Preparation ofKaranjin. Karanjin was prepared (>95%
pure) in the laboratory. Extraction of oil from karanja seeds
was carried out using petroleum ether (1:2 w/v). Oil was
subjected to liquid–liquid extraction with methanol. Karan-
jin was obtained from methanolic extract by preparative
HPLC. Karanjin thus obtained was characterized by 1Ha n d
13C nuclear magnetic resonance (NMR) and mass spectral
analysis.
2.2.2. Preparation of H+,K +-ATPase. Gastric membrane
containing H+,K +-ATPase was prepared [21]f r o mm u c o s a l
stomach scrapings of sheep and was homogenized in 20 mM
Tris–HCl buﬀer (pH 7.4). The homogenate was centrifuged
for 20min at 6000g and the resulting supernatant was used
todeterminetheH+,K +-ATPaseactivityanditsinhibition,as
standardized in our laboratory previously [22]. The protein
content of the supernatant was determined by Bradford’s
method using bovine serum albumin as a standard [23].
The enzyme extract containing 300µgp r o t e i nw a st a k e n
for testing the activity of H+,K +-ATPase. Reaction was
carried out in 16mM Tris buﬀer (pH 6.5). The reaction
was initiated by adding substrate (2mM ATP, 2mM MgCl2
and 10mM KCl) and incubated for 30min at 37◦C. The
reaction was stopped by the addition of an assay mixture
containing 4.5% ammonium molybdate and 60% perchloric
acid. Phosphomolybdate formed was measured spectropho-
tometrically at 400nm. Enzymatic activity was calculated as
micromoles of inorganic phosphate (Pi) released per hour
per milligram of protein.
2.2.3. Inhibition of H+,K +-ATPase In Vitro. The enzyme
extract containing 300µg of protein was taken for testing
the activity of H+,K +-ATPase in the presence of diﬀerent
concentrations (8–56µgmL −1) of karanjin. Lansoprazole,
a known proton-pump blocker, was employed as a stan-
dard anti-ulcer drug for comparative studies. Karanjin was
incubated with H+,K +-ATPase for 30 min. Subsequently,
reaction was carried out as described above. Enzymatic
a c t i v i t yw a sc a l c u l a t e da sm i c r o m o l e so fP ir e l e a s e dp e r
hour per milligram of protein at diﬀerent concentrations of
karanjin and results were expressed as percent inhibition of
enzymatic activity at each concentration.
2.3. Animals. Male Wistar albino rats, weighing ∼180–200g
and maintained under standard conditions of temperature,
humidity and light, were provided with standard rat palette
diet (Saidurga Feeds, Bangalore, India) and water ad libi-
tum. The study was approved by the institutional ethical
committee, which follows the guidelines of Committee for
the Purpose of Control and Supervision of Experiments on
Animals(CPCSEA,Reg.No.49,1999),GovernmentofIndia,
New Delhi, India.
2.3.1. Toxicity Studies. Toxicity studies were carried out for
15 days in control and karanjin-treated (20mgkg−1 b.w.)
rats. Serum was used for the estimation of total protein
and enzymes related to liver function tests, such as serum
glutamate pyruvate transaminase (SGPT), serum glutamate
oxaloacetate transaminase (SGOT) and alkaline phosphatase
(ALP).
2.3.2. Experimental Design. All the animals were categorized
into eight groups with six animals in each group, in
two sets for studies on swim and alcohol stress-induced
models. There were four control groups, such as healthy,
karanjin (20mgkg−1 b.w.), omeprazole as positive con-
trol (20mgkg−1 b.w.) and vehicle control groups. Karanjin
was administered at two concentrations, that is, 10 and
20mgkg−1 b.w. Omeprazole was given to one group at
20mgkg−1 b.w. concentration. Ulcer was induced in oneEvidence-Based Complementary and Alternative Medicine 3
group of animals without any pre-treatments. Karanjin and
omeprazole were administered orally once daily, for 14 days.
At the end of the 14th day, animals were fasted for 18h
a n do nt h e1 5 t hd a yt h e yw e r es u b j e c t e dt ou l c e r - i n d u c i n g
treatment.
2.3.3. Induction of Ulcer and Determination of Ulcer Index.
Ulcers were induced in the ﬁrst set of rats by administering
100% ethanol (5mL kg−1 b.w.) and animals were sacriﬁced
after 1h of ethanol treatment [24]. In other set, ulcers were
induced by forced swim stress as per a published protocol
[25], in which rats were brieﬂy subjected to forced swim
stress by making them swim in a jar 30-cm high and of
10cm diameter which contained water up to 15cm height
for 3h. Animals were sacriﬁced under deep ether anesthesia
and the inner layer of the stomach was examined for the
occurrence of ulcers. Low-to-high grading was assigned to
milder to severe symptoms, respectively. The following are
descriptions of ulcers groups; 0.5—red coloration, 1.0—
spot ulcers, 1.5—hemorrhagic streaks, 2.0—ulcers >3mm
and <5mm, 3.0—ulcers >5mm. Mean ulcer scores for each
experimental groups were calculated and expressed as the
ulcer index (UI) [26]. Stomach and liver-tissue homogenate
and serum were collected from all animals and analyzed for
various biochemical parameters.
2.3.4. Preparation of Tissue Homogenate for Biochemical
Analysis. The stomach and the liver tissues were collected,
weighed and homogenized in chilled phosphate buﬀer
(20mM, pH 7.4). The homogenates were centrifuged at
1000g at 4◦C for 20min using a high-speed cooling cen-
trifuge (Remi C 24, Mumbai, India). The clear supernatants
were analyzed for various biochemical parameters.
2.3.5. Estimation of Gastric Mucin. Gastric mucin was esti-
mated by Alcian blue-binding method [27]. A sample of
100mg of stomach tissues from animals of each group
was taken and incubated for 2h in acetate buﬀer (pH 5.8,
0.05M)containing 0.16Msucrose and1.0%Alcianbluedye.
Absorbance of the supernatant was read at 498nm.
2.3.6. Estimation of H+,K +-ATPase. Equal weight of gastric
tissue from animals of each group was homogenized in
Tris–HCl buﬀer (16mM, pH 6.5). The homogenates were
centrifuged at 6000g for 20min at 4◦C. The activity of
H+,K +-ATPase in the supernatant was assessed as described
previously.
2.3.7. Estimation of Oxidant/Antioxidant and Antioxidant
Enzymes. Lipid peroxidation products of serum, stomach
and liver homogenates were determined as thiobarbituri-
cacid reactive substances (TBARS). The malondialdehyde
(MDA) formed was quantiﬁed using the molar extinction
coeﬃcient of the MDA molecule [28]. Glutathione (GSH)
content was determined [29]. The activity of superoxide
dismutase (SOD) was determined by measuring the reduc-
tion in the auto-oxidation of epinephrine in the presence of
SOD [30]. Catalase (CAT) was assayed by decomposition of
H2O2 in the presence of CAT at 240nm [31]. Glutathione
peroxidase (GPx) was estimated based on the degradation of
H2O2 in the presence of GSH and the decrease in absorbance
was read at 340nm [32].
SOD activity was expressed as units per milligram of
proteinperminute (1unit = milligram ofprotein requiredto
inhibit50%ofepinephrineauto-oxidation)andCATactivity
was expressed as micromoles of H2O2 utilized by milligram
of protein per minute. The activity of GPx was expressed as
nanomoles of nicotinamide adenine dinucleotide phosphate
(NADPH) oxidized per minute per milligram of protein.
The protein content of the homogenate was determined by
Bradford’s method.
2.3.8. Histopathological Studies. Gastric tissue samples were
ﬁxedin10%buﬀeredformalinfor24h.Theprocessedtissues
were embedded in paraﬃn blocks and sections made were
stained with hematoxylin and eosin dye [33]. The sections
were analyzed by observing under light microscope at ×10
magniﬁcation.
2.4. Statistical Analysis. All the values are expressed as mean
± SD. Signiﬁcant diﬀerence between healthy, treated and
ulcer-induced groups was tested (P<. 05) by Duncan
multiple-range test using the Statistical Package for Social
Sciences (SPSS; SPSS Inc., version 10.0.5) software.
3.Results
3.1. Inhibition of H+,K +-ATPase, and Antioxidant Activity
of Karanjin In Vitro. Diﬀerent concentrations (8–56µg) of
karanjin showed 10–86% inhibition of H+,K +-ATPase.
These studies indicated that karanjin possesses inhibitory
activity on H+,K +-ATPase with an IC50 value of 39.5 ±
4.23µgm L −1 against a standard inhibitor, lansoprazole that
showed an IC50 value of 19.3 ± 2.2µgm L −1 (Figure 1).
3.2. Toxicity Studies. Toxicity studies(Table 1)with karanjin,
carried out in rats for safety evaluation, indicated no lethal
eﬀectupto20mgkg−1 b.w. whenorallyfedfor14days.Para-
metric values, however, showed slight variation as indicated
by P-values; nevertheless, the values are within the reference
range as per the range of values provided by the National
InstituteofNutritionManual [34]indictingno adverseeﬀect
on major organs at the ingested concentrations. After the
treatment schedule, animals remained as healthy as control
animals with normal food and water intake and body weight
gain.
3.3. Eﬀect of Karanjin on Swim/Ethanol Stress-Induced
Gastric Ulcer. Healthy rats did not show ulcer lesions
in their stomachs (Figure 2(a)), while rats treated with
forced swim stress and ethanol stress showed damage
in the gastric wall with a hemorrhagic form of lesions
and intraluminal bleeding (Figures 2(d) and 2(g)). Rats
treated with only karanjin (Figure 2(c))s h o w e dn ol e s i o n s ,
which is similar to those of controls indicating no toxicity.
Omeprazole, at 20mgkg−1 b.w., showed protective eﬀect4 Evidence-Based Complementary and Alternative Medicine
120
100
80
60
40
20
0
0 8 16 24 32 40 48 56 64
Concentration (μg/mL)
Karanjin
Lansoprazole
I
n
h
i
b
i
t
i
o
n
(
%
)
Figure 1: Inhibition of H+,K +-ATPase in vitro by karanjin (open
diamond) in comparisonwith lansoprazole(open circle).
in case of both swim and ethanol stress-induced ulcers
(Figures 2(j) and 2(k)). In case of swim stress, karanjin
at 10 and 20mgkg−1 b.w. reduced ulcers up to 50% in a
dose-dependent manner (Figures 2(e) and 2(f)). However,
karanjin showed marginal protection in case of ethanol
stress-induced ulcers (Figures 2(h) and 2(i)). Quantitative
reduction in UI percentage in treated rats, compared with
ulcer-induced rats is depicted in Figure 3.
3.4. Analysis of Gastric Mucin. It is well established that
gastric wall mucusisdamagedduringulcerdevelopmentand
becomes the ﬁrst target for stress-induced reactive oxygen
species (ROS); this is followed by mucin oxidation or degra-
dationand the mucussubsequentlylosesthe protectiveeﬀect
[35]. Since Alcian blue binds to carboxylated mucopolysac-
charides as well as sulfated and carboxylated glycoproteins,
any disruption in structure results in the reduction in
dye binding, which can be quantiﬁed. The gastric mucin
was decreased to 15mgg−1 tissue in swim stress-induced
ulcerous rats, when compared to that of controls (54mg g−1
tissue). Rats treated with 10 and 20mgkg−1 b.w. karanjin
showed ∼3-fold increase in mucin level. Similar results
were obtained in rats that were treated with omeprazole.
In ethanol stress-induced ulcerous rats however, there was
no improvement in the mucin regeneration despite karanjin
treatment (Table 2).
3.5. H+,K +-ATPase Activity. H+,K +-ATPase enzyme was
increased 2-fold in ulcerous animals over healthy con-
trols. Karanjin could normalize the levels in vivo in both
swim/ethanol stress-induced models. The extent of inhibi-
tion was comparable to that of the known anti-ulcer drug
omeprazole (Table 2).
3.6. Oxidant/Antioxidant/Antioxidant Enzymes and Lipid
Peroxidation Levels. Approximately 3-fold increase in
TBARS levels (0.44nmolmg−1 of protein) shown in the
Table 1: Toxicity studies with karanjin.
Parameters Healthy
control
Karanjin treated
(20mg kg−1 b.w.) P-value
Proteins (mg dL−1) 3583 ± 30.6 3613 ± 44.9 .350
SGOT (U L−1) 90.6 ± 6.2 74.8 ± 7.4 .044
SGPT (U L−1) 41.5 ± 3.0 31.5 ± 8.6 .109
ALP (U L−1) 182.3 ± 24.3 168.4 ± 22.2 .459
(n = 6), mean ± SD.
Table 2: Gastric mucin and H+K+-ATPase levels in healthy,
ulcerated and protected rats.
Groups Mucin content
(mg g−1)
H+K+-ATPase
(µmol Pi mg−1)
Ethanol stress-induced ulcer
model
Healthy 54.05a ± 5.5 0.57a ± 0.18
Ethanol stress induced 14.05b ± 2.5 1.04b ± 0.14
Karanjin control 20mg kg−1 b.w. 49.75a ± 9.4 0.58a ± 0.10
Karanjin 10mg kg−1 b.w. 14.53b ± 3.8 0.73c ± 0.08
Karanjin 20mg kg−1 b.w. 25.25b ± 8.3 0.61a ± 0.10
Omeprazole control 50.60a ± 11.7 0.51a ± 0.09
Omeprazole 20mg kg−1 b.w. 50.86a ± 6.0 0.58a ± 0.03
Oil treated 20.57b ± 8.9 0.95b ± 0.08
Swim stress-induced ulcer model
Healthy 54.05a ± 5.5 0.44a, c ± 0.15
Swim stress induced 15.00d ± 2.9 0.93b ± 0.14
Karanjin control 20mg kg−1 b.w. 51.19a,c ± 4.8 0.45a ± 0.15
Karanjin 10mg kg−1 b.w. 40.95b ± 6.9 0.58c ± 0.11
Karanjin 20mg kg−1 of body 46.28b, c ± 5.7 0.49a, c ± 0.12
Omeprazole control 50.09a,c ± 3.8 0.56a, c ± 0.15
Omeprazole 20mg kg−1 b.w 50.24a,c ± 4.3 0.59c ± 0.15
Oil treated 20.23d ± 3.9 0.91b ± 0.13
Results are expressed as mean ± SD (n = 6). Range was provided by
Duncan multiple-range test at P<. 05. Diﬀerent letters a–d in the column
represent values that are signiﬁcantly diﬀerent when ulcer-induced group
was compared with healthy control and sample-treated groups. aless or not
signiﬁcant; bmoderately signiﬁcant; cless signiﬁcant and dvery signiﬁcant.
stomach homogenate in ulcer condition was normalized
(0.17nmolmg−1protein) by karanjin at 20mgkg−1 b.w.,
similar to the extent of protection oﬀered by omeprazole
(0.14nmolmg−1 of protein; Tables 3 and 4). Similarly,
2-fold-depleted antioxidant enzymes—SOD, GPx and
CAT—during ulcer conditions were normalized with the
treatment of rats with karanjin at 10 and 20mg kg−1 b.w.
(Tables 3 and 4).
3.7. Histopathological Analysis. Healthy controls showed
intact mucosal epithelium (Figure 4(a)). Deep erosions with
discontinuous mucosal layer were observed in ulcer-induced
rats (Figures 4(d) and 4(g)). In case of swim stress, almost
completerecoveryofthemucosallayerwasobserved(Figures
4(e) and 4(f)) in karanjin-treated groups, substantiating the
results observed as UI. However, in ethanol stress-inducedEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Macroscopic observation of ulcers in induced/protected stomachs in swim/ethanol stress-induced ulcer models. In healthy,
karanjin control and omeprazole control, no ulcer lesions were observed. In ethanol and swim stress-induced animals, ulcer scores were
very high as shown by arrows. Karanjin- and omeprazole-treated animals showed reduced stomach lesions.
ulcers, karanjin was not able to protect the mucin layer
(Figures 4(h) and 4(i)).
4.Discussion
Pongamia pinnata is a medium-sized glabrous tree, found
throughout India and further distributed eastwards, mainly
in the littoral regions of Southeast Asia and Australia [19,
36]. The seed and seed oil are in use for the treatment
of various inﬂammatory and infectious diseases, such as
leucoderma, leprosy, lumbago and muscular and articular
rheumatism [37]. Although only a few eﬀorts have been
made to rationalize the conventional uses of karanja, some
pharmacological properties have been established, which6 Evidence-Based Complementary and Alternative Medicine
120
100
80
60
40
20
0
Healthy Ulcer Karanjin
10mg
Karanjin
20mg
Omeprazole
20mg
Ethanol stress
Swim stress
aa
b
b
c
c
d
d
d
e
U
l
c
e
r
i
n
d
e
x
Figure 3: Eﬀect of karanjin on gastric lesions in swim/ethanol
stress-induced ulcer models; Ulcers were scored as described under
the methods and expressed as ulcer index. The letters “a” to “e”
represents level of signiﬁcant diﬀerences among healthy, ulcer-
induced and treated groups, where, a, less or not signiﬁcant; b, less
signiﬁcant;c, moderately signiﬁcant;d, very signiﬁcant and e, most
signiﬁcant.
indicate that sequential extraction with diﬀerent solvents
exhibitsdiﬀerentialbioactivity includingulcerhealing.How-
ever, the active constituents responsible for the activity are
not clearly understood.
Ulcers result from an imbalance between aggressive
factors and maintenance of mucosal integrity through the
endogenous defense mechanisms. To regain the balance,
diﬀerent therapeutics, including spice and plant extracts, are
used. In the previous papers we had shown that free and
bound phenolics of several food sources, including ginger
[38], swallow root [15] and mango ginger [39], possessed
potential ulcer-preventive activity in vitro, including inhibi-
tion of H+,K +-ATPase and H. pylori growth. However, in
view of addressing a question whether karanjin, a furano-
ﬂavonoid being a major component in karanja extract,
can be attributed to observed gastroprotective properties
of karanja extract [18], we evaluated in vitro and in
vivo ulcer-preventive properties of isolated and puriﬁed
karanjin.
Results of the study indicated the presence of signiﬁcant
(95%) levels of karanjin and structural studies including
HPLC, liquid chromatography-mass spectroscopy (LC-MS)
and NMR conﬁrmed that the speciﬁcally extracted karanjin
indeed is homogenous and pure. Karanjin could inhibit
swim stress-induced ulcers by 50 and 74% at 10 and
20mgkg−1 b.w.; however, only marginal protection was
observed in ethanol stress-induced ulcerous rats at similar
concentrations of karanjin. Karanjin controls and vehicle-
treated animals showed neither the toxicity of karanjin as
evaluated by analysis of liver marker enzymes (Table 1)n o r
protection by vehicle alone suggesting that the diﬀerential
results observed in two diﬀerent models are speciﬁc changes
brought about by karanjin. Furthermore, data also may
highlight that karanjin might protect signiﬁcantly from the
acid-induced mucosal damage and ulcerations by blocking
H+,K +-ATPase activity in swim stress model while the
ethanol stress-induced mucosal damage that is induced by
ethanol via a mechanism initiated by inadequatemicrocircu-
lation may not be inhibited. Figure 5 depicts the induction
of ulcers via diﬀerent mechanisms by swim/ethanol stress
models. ROS, however, accumulate in both the models and
cause activation of H+,K +-ATPase leading to gastric acidity,
mucosal layer damage and gastric ulcerations in addition to
the inadequatemicrocirculation encounteredduring ethanol
stress. Multi-step inhibitory eﬀect has been highlighted in
the scheme. Lacunae in the eﬀective protection ability of
karanjin in ethanol stress model while complete protection
inswim stress modelsuggeststheinabilityofprotectiveeﬀect
of karanjin against inadequate microcirculation while potent
H+,K +-ATPase inhibitory and antioxidant properties that
can oﬀer eﬀective protection against swim stress-induced
ulcers.
Etiology of induction of ulcers in diﬀerent models needs
to be considered to understand the diﬀerential role of
karanjin. Ethanol has been known to damage the plasma
membraneandleadstointracellularaccumulationofsodium
and water by increasing the membrane permeability. These
changes ultimately cause cell death and gastric mucosal
exfoliation [40]. Obviously, inadequate microcirculation
in mucosal cell results in mucosal injury. Recovery of
these damages requires processes such as active release of
prostaglandin E2 that enhances the proliferation of mucosal
cells to produce mucin and rejuvenate the damaged layer, as
revealed by our previous study [41]. Furthermore, ethanol is
knownalso torelease theendogenousulcerogenicmediators,
which could rapidly induce mucosal injury either by causing
vascular changes such as mucosal edema and increased
mucosal permeability [42] or by non-vascular eﬀects such
as mucus depletion and enzyme release in the stomach
[43]. Swim stress, on the other hand, induces activation
of parietal-cell membrane H+,K +-ATPase enzyme which
enhances the inﬂux of H+ into the lumen of the stomach
leading to acidity and acid-induced mucosal injury at later
stages [15]. Association between severe physiological stress
and gastrointestinal (GI) ulceration is well established. The
pathology of stress-related mucosal damage has not been
described completely, but there is a strong evidence that
hypo-perfusion of the upper GI tract is a major cause.
Aggressive management of theunderlying disease is themost
important factor in the prevention of stress ulcerations.
Consideration of the mechanism of injury certainly may
help in understanding the diﬀerential role of karanjin in two
diﬀerent models.
The current result of karanjin that was eﬀective in
regenerating mucin which is important for mucosal pro-
tection up to 76% and 86% at 10 and 20mgkg−1 b.w.
in the swim stress model. However, <47% mucin recovery
in ethanol stress-induced models together with eﬀective
blocking of H+,K +-ATPase activity in both the mod-
els may suggest that, in swim stress, initiation of ulcer
pathogenicity may be due to activation of H+,K +-ATPase
activity; conversely, in ethanol stress-induced models, it is
due to exfoliation and aberrant microcirculation followed
by increase in H+,K +-ATPase activity leading to acidityEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Histopathological observation of stomach from ulcer-induced and karanjin/omeprazole-treated animals. The above ﬁgures
indicate hematoxylin-and-eosin-stained sections (magniﬁcation ×10). Healthy, omeprazole control and karanjin control groups show an
intact mucosal epithelium (indicated by arrows a, b and c) with organized glandular structure (a ) .E Sa n dS Ss h o w sd a m a g e dm u c o s a l
epithelium and disrupted glandular structure (d, g and g ). Karanjin pre-treatment reduced epithelial damage in addition to reorganized
glandular structures in ethanol (h and i) and swim stress-induced ulcer conditions (e and f). Oil used as a vehicle control did not show
mucosalprotection (l and l ).
and ulcerations. Thus, karanjin may be believed to protect
swim stress-induced ulcers by virtue of inhibition of H+,
K+-ATPase activity. This indication was substantiated by
the poor improvement of UI in ethanol stress-induced
ulcerated rats. Karanjin may be ineﬀective in preventing
the ethanol stress-induced mucosal cell damage, although it
could inhibit injury-mediated activation of H+,K +-ATPase.
Further, studies suggest that proton-pump blockers may be
eﬀectiveagainststress-induced ulcers.Omeprazole,aknown,
potent H+,K +-ATPase blocker, worked eﬀectively in both
the models suggesting the multi-step action of omeprazole
[44].
It is also interesting to observe that the levels of antiox-
idant enzymes were brought to normal levels in both swim
and ethanol stress-induced ulcerated rats upon treatment
with karanjin. Observed marginal (47%) levels of gastric
protection in ethanol stress-induced ulcer model could be
by virtue of the antioxidant property of karanjin, although
to a lesser extent. Data could thus imply that karanjin can
be an eﬀective anti-ulcer agent. Further, being non-toxic, it
may also be used in combination with other nutraceuticals
for eﬀective management of oxidative stress-induced disease
conditions.
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Table 3: Antioxidant/antioxidant enzymes and TBARS levels in stomach homogenates of swim/ethanolstress-induced ulcer model.
Groups GSH
(nmol g−1 tissue)
TBARS
(nmol mg−1 protein)
SOD
(U mg−1 protein)
Catalase
(µmolmg−1 protein)
Glutathione
Peroxidase
(nmol mg−1 protein)
Swim stress
Healthy 395.3a ± 73.9 0.16b ± 0.08 32.87a ± 3.4 15.99b ± 2.0 2.62c ± 0.2
Swim stress induced 183.9d ± 4.3 0.44a ± 0.20 15.62e ± 0.4 8.88c ± 1.5 1.30e ± 0.1
Karanjin control 315.5e ± 50.9 0.17b ± 0.20 38.16c ± 1.8 16.91b ± 2.1 2.49c ± 0.8
Karanjin 10mgkg−1 b.w. 429.3b, c ± 50.1 0.21c ± 0.15 38.02c ± 5.3 15.40b ± 1.0 1.70a, e ± 0.7
Karanjin 20mgkg−1 b.w. 473.8b ± 45.6 0.17b ± 0.06 44.45b ± 2.5 16.79b ± 0.9 2.38c ± 0.5
Omeprazole control 411.8a, c ± 39.6 0.16b ± 0.09 36.28a,c ± 1.7 15.20b ± 3.3 3.16b ± 1.6
Omeprazole
20mgkg−1 b.w. 391.8a ± 44.2 0.14b ± 0.05 36.14a,c ± 3.3 15.24b ± 1.5 2.06a, c ± 0.7
Oil treated 177.8d ± 51.5 0.24a ± 0.06 15.16e ± 0.9 9.04c ± 0.9 1.40e ± 0.0
Ethanol stress
Healthy 181.5b ± 37.6 0.16b ± 0.08
Not tested
17.09a,c ± 1.5
Not tested
Ethanol stress induced 110.8e ± 40.0 0.44c ± 0.20 8.30e ± 3.3
Karanjin control 294.1b, c ± 57.1 0.17b ± 0.07 18.31b, c ± 5.0
Karanjin 10mgkg−1
b.w. 211.5b, c ± 89.5 0.21b ± 0.05 15.36a ± 2.8
Karanjin 20mgkg−1
b.w. 233.6a, c ± 41.3 0.17b ± 0.06 17.38b, c ± 2.3
Omeprazole control 261.5a ± 38.5 0.16b ± 0.09 19.37b ± 4.1
Omeprazole
20mgkg−1 b.w. 210.1b ± 59.0 0.14b ± 0.05 15.82a ± 1.5
Oil treated 125.9b ± 33.8 0.44c ± 0.06 8.02e ± 1.5
Results are expressed as mean ± SD (n = 6). Range was provided by Duncan multiple-range test at P<. 05. Diﬀerent letters a–d in the column represent
values that are signiﬁcantlydiﬀerent when ulcer-induced group was compared with healthy control and sample-treated groups. amoderately signiﬁcant; bless
or not signiﬁcant; cless signiﬁcant and dmost signiﬁcant.
Table 4: Antioxidant/antioxidant enzyme and TBARS levels in liver homogenate and serum of swim stress-induced ulcer model.
Groups GSH (nmolg−1 tissue) TBARS (nmolmg−1 protein) SOD (Umg−1 protein)
Liver
Healthy 236.6a ± 47.7 1.31a,b ±0.4 27.04a, b ± 3.4
Swim stress induced 157.3c ± 12.2 4.04d ± 1.1 15.78d ± 3.7
Karanjin control 215.1a ± 29.6 1.43a, b ± 0.3 26.14a,c ± 2.1
Karanjin 10mgkg−1 b.w. 217.3a ± 20.2 1.86c ± 0.5 25.21c ± 3.2
Karanjin 20mgkg−1 b.w. 292.3b ± 73.9 1.71a,c ± 0.5 30.38b ± 2.9
Omeprazole control 218.1a ± 18.2 1.16b ± 0.4 26.41a,c ± 3.1
Omeprazole 20mgkg−1 b.w. 222.1a ± 16.9 1.53a, b ± 0.3 28.93a, b ± 2.7
Oil treated 110.2a ± 19.5 1.92c ± 0.3 17.00d ± 1.9
Serum
Healthy 10.6a, b ± 2.3 0.077b ± 0.04 2.28b ± 0.3
Swim stress induced 5.9d ± 0.8 0.190c ± 0.007 1.12d ± 0.1
Karanjin control 10.1a, b ± 1.4 0.065b ± 0.007 2.10a, b ± 0.3
Karanjin 10mg kg−1 b.w. 8.9a, c ± 1.1 0.079b ± 0.001 1.97a,c ± 0.1
Karanjin 20mg kg−1 b.w. 11.6b ± 1.2 0.073b ± 0.003 2.19a, b ± 0.2
Omeprazole control 8.0c ± 2.0 0.077b ± 0.005 2.35b ± 0.3
Omeprazole 20mg kg−1 b.w. 10.5a, b ± 3.9 0.075b ± 0.007 1.81c ± 0.2
Oil treated 5.1d ± 0.1 0.135a ± 0.017 1.36d ± 0.2
Results are expressed as mean ± SD (n = 6). Range was provided by Duncan multiple-range test at P<. 05. Diﬀerent letters a–d in the column represent
values that are signiﬁcantly diﬀerent when ulcer induced group was compared with healthy control and sample treated groups. aless signiﬁcant; bless or not
signiﬁcant; cmoderately signiﬁcant and dvery signiﬁcant.Evidence-Based Complementary and Alternative Medicine 9
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Figure 5: Mechanism of ulcer induction; multi-step protection
by karanjin. In stress (1)–swim (2)/ethanol (3) model, ulcer (8)
induction is via accumulation of reactive oxygen species (ROS)
(4), activation of H+,K +-ATPase (5), increase in acidity (6) and
damageofmucosallayer(7)while,inethanolstress,itismoredirect
and via damage of mucosal layer due to lack of microcirculation.
Karanjinprotects multi-steps which includesinhibitionofROS (A),
inhibition of H+,K +-ATPase (B) and mucosal protection (C). It
is also possible that karanjin, like most of the phenolics, may just
regulate proton pump via dehydrogenase coupling.
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